Title : Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.

Pub. Date : 2015 Jun 30

PMID : 26009874






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a combination regimen, Sabutoclax and COX-2 inhibitor, Celecoxib, synergistically inhibited the growth of OSCC in vitro and also significantly reduced OSCC tumor growth in vivo. Celecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens